These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 19048929
21. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, Djakovic N, Pahernik S, Hohenfellner M. BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772 [Abstract] [Full Text] [Related]
23. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial. Elmansy HM, Elzayat E, Elhilali MM. J Urol; 2010 Nov; 184(5):2023-8. PubMed ID: 20850828 [Abstract] [Full Text] [Related]
24. [Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser]. Lipiński MI, Peszyński-Drews C, Jeromin MZ, Jeromin LM. Wiad Lek; 2006 Nov; 59(3-4):196-8. PubMed ID: 16813263 [Abstract] [Full Text] [Related]
25. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention. Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urology; 2006 Aug; 68(2):312-7. PubMed ID: 16904443 [Abstract] [Full Text] [Related]
28. [Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan]. Kuromatsu I, Imamura T, Sugimura Y. Nihon Hinyokika Gakkai Zasshi; 2006 Nov; 97(7):815-22. PubMed ID: 17154023 [Abstract] [Full Text] [Related]
29. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Hamann MF, Naumann CM, Seif C, van der Horst C, Jünemann KP, Braun PM. Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565 [Abstract] [Full Text] [Related]
31. [A comparative study on the photoselective vaporization of the prostate and transurethral electrovaporization resection of prostate for the treatment of benign prostatic hyperplasia]. Yang Y, Hong BF, Fu WJ, Xu Y, Chen YF, Zhang CE. Zhonghua Wai Ke Za Zhi; 2007 Jul 15; 45(14):951-3. PubMed ID: 17961377 [Abstract] [Full Text] [Related]
33. Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true? Araki M, Lam PN, Culkin DJ, Wong C. Urology; 2007 Nov 15; 70(5):927-30. PubMed ID: 18068449 [Abstract] [Full Text] [Related]
35. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study. Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Dellis A, Kastriotis I, Deliveliotis C. Eur Urol; 2008 Aug 15; 54(2):427-37. PubMed ID: 18069117 [Abstract] [Full Text] [Related]
38. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. Elzayat E, Habib E, Elhilali M. J Urol; 2006 Apr 15; 175(4):1428-32. PubMed ID: 16516015 [Abstract] [Full Text] [Related]
39. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE. J Urol; 2011 Sep 15; 186(3):977-81. PubMed ID: 21791350 [Abstract] [Full Text] [Related]
40. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. Malde S, Rajagopalan A, Patel N, Simoes A, Choi W, Shrotri N. J Endourol; 2012 Jul 15; 26(7):878-83. PubMed ID: 22260554 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]